|
MechanismTubulin inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1995 |
|
MechanismCav2.1 inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date01 May 1981 |
100 Clinical Results associated with Hikma International Pharmaceuticals LLC
0 Patents (Medical) associated with Hikma International Pharmaceuticals LLC
100 Deals associated with Hikma International Pharmaceuticals LLC
100 Translational Medicine associated with Hikma International Pharmaceuticals LLC